Rolf Kiessling

Karolinska Institutet — Sweden

Immunology and Microbiology · Life Sciences

90h-index29.4kcitations540works13.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(215), Immunotherapy and Immune Responses(204), T-cell and B-cell Immunology(106), Cancer Immunotherapy and Biomarkers(90), CAR-T cell therapy research(88)

Publications539 total

Editorial Expression of Concern: Retinoic acid elicits cytostatic, cytotoxic and immunomodulatory effects on uveal melanoma cells
Cancer Immunology Immunotherapy·2026Open Access
Palbociclib CDK4/6- and Crizotinib MET/ALK/ROS1-inhibitors Synergize to Enhance Senescence and Immune Recognition in Melanoma Cells Independently of <i>BRAF</i> / <i>NRAS</i> Status
2025Open Access
[Cell therapy with tumor infiltrating lymphocytes; a therapeutic alternative for malignant melanoma and soon also other types of cancer].
PubMed·2025
Reactive oxygen species: Janus-faced molecules in the era of modern cancer therapy
Journal for ImmunoTherapy of Cancer·2024· 13 citedOpen Access
Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis
Science Translational Medicine·2024· 53 cited
Figure S3 from Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma
2023Open Access
Figure S1 from Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma
2023Open Access
Figure S5 from Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma
2023Open Access
Figure S4 from Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma
2023Open Access
Figure S1 from Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma
2023Open Access
Table S1 from Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma
2023Open Access
Supplementary Figures 1 and 2 from Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production
2023Open Access
Figure S6 from Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma
2023Open Access
Figure S7 from Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma
2023Open Access
Figure S3 from Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma
2023Open Access
Data from Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production
2023Open Access
Figure S6 from Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma
2023Open Access
Supplementary Tables 1 and 2 from Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production
2023Open Access
Figure S5 from Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma
2023Open Access
Supplementary Figures 1 and 2 from Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production
2023Open Access
page 1 of 27Next →

Frequent Co-authors

Hans Wigzell(9), Max Petersson(8), Dimitrios Mougiakakos(7), Isabel Poschke(6), Klas Kärre(5), Andreas Lundqvist(5), Giuseppe Masucci(5), Hans‐Gustaf Ljunggren(4), Otto Haller(4), C. Christian Johansson(4), Koji Kono(4), Pavel Pisa(4), Håkan Norell(4), Karl‐Johan Malmberg(4), Birger Andersson(4), Eva Klein(3), Jehad Charo(3), Barbara Seliger(3), Johan Hansson(3), Masanori Matsuda(3)